{"organizations": [], "uuid": "00055664346e2d3c9c7ad0acc7a5e9009df4bea1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 1, "shares": 1, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180213.html", "section_title": "Archive News &amp; Video for Tuesday, 13 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-barry-honig-reports-499-pct-stake/brief-barry-honig-reports-4-99-pct-stake-in-mabvax-therapeutics-idUSFWN1Q30XW", "country": "US", "domain_rank": 408, "title": "Barry Honig Reports 4.99 Pct Stake In MabVax Therapeutics", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.066, "site_type": "news", "published": "2018-02-13T19:44:00.000+02:00", "replies_count": 0, "uuid": "00055664346e2d3c9c7ad0acc7a5e9009df4bea1"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-barry-honig-reports-499-pct-stake/brief-barry-honig-reports-4-99-pct-stake-in-mabvax-therapeutics-idUSFWN1Q30XW", "ord_in_thread": 0, "title": "Barry Honig Reports 4.99 Pct Stake In MabVax Therapeutics", "locations": [], "entities": {"persons": [{"name": "barry honig", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "mabvax therapeutics holdings inc", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "thomson reuters trust principles", "sentiment": "none"}, {"name": "bvax therapeutics holdings inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 13 (Reuters) - MabVax Therapeutics Holdings Inc :\n* BARRY HONIG REPORTS 4.99 PERCENT STAKE IN MABVAX THERAPEUTICS HOLDINGS INC AS OF FEBRUARY 12, 2018 - SEC FILING‍​\n* BARRY HONIG SAYS MAY ENGAGE IN DISCUSSIONS WITH MANAGEMENT, SECURITY HOLDERS OF MABVAX REGARDING COMPLEXION OF CO’S BOARD OF DIRECTORS, OPTIONS FOR INCREASING SHAREHOLDER VALUE Source text: ( bit.ly/2EmknVf ) Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "http://bit.ly/2EmknVf"], "published": "2018-02-13T19:44:00.000+02:00", "crawled": "2018-02-14T12:27:16.073+02:00", "highlightTitle": ""}